Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T, Sada KE, Yan M, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Watanabe H, Katsuyama E, Takano-Narazaki M, Toyota-Tatebe N, Sunahori-Watanabe K, Kawabata T, Miyake K, Kiguchi T, Wada J.
Katsuyama T, et al. Among authors: katsuyama e.
Mod Rheumatol. 2017 Sep;27(5):773-777. doi: 10.1080/14397595.2016.1259714. Epub 2016 Dec 15.
Mod Rheumatol. 2017.
PMID: 27846761